Adam Lauring, MD, PhD
Professor of Internal Medicine
Professor of Microbiology and Immunology
Professor of Ecology and Evolutionary Biology
College of Literature, Science, and the Arts
[email protected]

Available to mentor
Adam Lauring, MD, PhD
Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications
    • About

    Dr. Lauring is a physician-scientist with a research interest in the genetics and evolution of RNA viruses

    Links
    • Lauring Lab
    Qualifications
    • MD
      University of Washington, Seattle, 2002
    • PhD
      University of Washington, Seattle, 2000
    • BS
      Yale University, New Haven, 1994
    Research Overview

    Dr. Lauring’s laboratory has worked in three main areas. First, they study the importance of mutation rate and mutational tolerance to the evolution of poliovirus and influenza virus. More recently, they have utilized next generation sequencing of patient samples to define the within-host evolution and transmission of influenza virus, poliovirus, and SARS-CoV-2. Since the beginning of the COVID pandemic, his laboratory has collaborated with large teams to study the genomic epidemiology of respiratory viruses and the effectiveness of vaccines against them.

    Recent Publications See All Publications
    • Journal Article
      Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.
      Lewis NM, Harker EJ, Leis A, Zhu Y, Talbot HK, Grijalva CG, Halasa N, Chappell JD, Johnson CA, Rice TW, Casey JD, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, DeCuir J, Surie D, Dawood FS, Ellington S, Self WH, Martin ET. Vaccine, 2024 Nov 7; 43 (Pt 2): 126492 DOI:10.1016/j.vaccine.2024.126492
      PMID: 39515195
    • Journal Article
      Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel.
      Fowlkes AL, Peretz A, Greenberg D, Hirsch A, Martin ET, Levine MZ, Edwards L, Radke S, Lauring AS, Ferdinands JM, Zhang C, Yoo YM, Dreiher J, Newes-Adeyi G, Azziz-Baumgartner E, Fry AM, Monto AS, Balicer R, Thompson MG, Katz MA. Int J Infect Dis, 2024 Oct 10; 149: 107260 DOI:10.1016/j.ijid.2024.107260
      PMID: 39395753
    • Journal Article
      Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study.
      Lewis NM, Harker EJ, Grant LB, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Busse LW, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Hough CL, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Martinez A, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Goyal A, DeLamielleure LE, DeCuir J, Surie D, Dawood FS, Tenforde MW, Uyeki TM, Garg S, Ellington S, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . Clin Infect Dis, 2024 Nov 28; DOI:10.1093/cid/ciae584
      PMID: 39607747
    • Journal Article
      Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.
      DeCuir J, Surie D, Zhu Y, Lauring AS, Gaglani M, McNeal T, Ghamande S, Peltan ID, Brown SM, Ginde AA, Steinwand A, Mohr NM, Gibbs KW, Hager DN, Ali H, Frosch A, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Khan A, Busse LW, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Exline MC, Shapiro NI, Columbus C, Vaughn IA, Ramesh M, Safdar B, Mosier JM, Casey JD, Talbot HK, Rice TW, Halasa N, Chappell JD, Grijalva CG, Baughman A, Womack KN, Rhoads JP, Swan SA, Johnson C, Lewis N, Ellington S, Dawood FS, McMorrow M, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . Influenza Other Respir Viruses, 2024 Nov; 18 (11): e70027 DOI:10.1111/irv.70027
      PMID: 39496339
    • Journal Article
      Effectiveness of the original monovalent mRNA COVID-19 vaccination series against hospitalization for COVID-19-associated venous thromboembolism.
      Hager DN, Zhu Y, Sohn I, Stubblefield WB, Streiff MB, Gaglani M, Steingrub JS, Duggal A, Felzer JR, O'Rourke M, Peltan ID, Mohamed A, Stiller R, Wilson JG, Qadir N, Ginde AA, Zepeski AE, Mallow C, Lauring AS, Johnson NJ, Gibbs KW, Kwon JH, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . J Infect Dis, 2024 Oct 15; DOI:10.1093/infdis/jiae502
      PMID: 39405261
    • Journal Article
      HLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection.
      Olp MD, Laufer VA, Valesano AL, Zimmerman A, Woodside KJ, Lu Y, Lauring AS, Cusick MF. Life (Basel), 2024 Sep 19; 14 (9): DOI:10.3390/life14091181
      PMID: 39337964
    • Journal Article
      HLA-C peptide repertoires as predictors of clinical response during early SARS-CoV-2 infection
      Olp M, Laufer V, Valesano A, Zimmerman A, Woodside K, Najor M, Lu Y, Lauring A, Cusick M. Human Immunology, 2024 Sep; 85: 110860 DOI:10.1016/j.humimm.2024.110860
    • Journal Article
      Respiratory Viral Infections from 2015 to 2022 in the HIVE Cohort of American Households: Incidence, illness characteristics, and seasonality.
      Monto AS, Foster-Tucker JE, Callear AP, Leis AM, Godonou E-T, Smith M, Truscon R, Johnson E, Thomas LJ, Thompson MS, Fry AM, Flannery B, Malosh RE, Petrie JG, Lauring AS, Martin ET. J Infect Dis, 2024 Aug 24; DOI:10.1093/infdis/jiae423
      PMID: 39179953
    Featured News & Stories pigs sick and chickens in background with blue background and green cells floating around
    Health Lab
    Why the bird flu’s jump to pigs is concerning
    A Michigan Medicine virologist speaks about the implications of H5N1 influenza, or bird flu, and whether a new pandemic could be on the horizon.
    News Release
    Building a COMPASS to navigate future pandemics
    An $18 million National Science Foundation grant will establish a new center to bring computer science, infectious disease, engineering, and the arts together to predict and prevent global pandemics
         Microscopic rendering of the flu virus with green, purple and red coloring
    News Release
    $10 million NIH-award establishes new U-M center to study genomics of infectious disease pathogens
    A new NIH award will establish the Michigan Infectious Disease Genomics (MIDGE) Center, the goal of which is to use whole genome sequencing and functional genomic assays to determine how genetic differences among strains or isolates affect the behavior, transmission, and drug resistance of viral, bacterial, and fungal pathogens.
         Q&A with trainees at MMMP scientific symposium, June 18, 2024
    Department News
    MMMP celebrates 25 years of its NIH T32 training grant
    The Department of Microbiology and Immunology (M&I) celebrated 25 years of its NIH T32 training grant that supports the Molecular Mechanisms in Microbial Pathogenesis Training Program (MMMP) with a scientific symposium, held June 18, 2024.
         Lab of Erin M. Janssen, M.D., Ph.D.
    Medical School News
    Labs go platinum: Research teams record efforts to achieve sustainability certification
    Many Michigan Medicine labs are taking time to ensure that they are doing their part to support the Medical School’s major initiatives, including the push for carbon neutrality.